These results suggested that TLR3 had the potential to be used as a diagnostic biomarker of KIRC, LGG and PAAD, especially as a biomarker for early diagnosis of KIRC and for pathological classification of LGG. Here, TLR3 is linked to pancreatic adenocarcinoma.